Literature DB >> 24078299

Methylene blue does not have to be considered only as rescue therapy for distributive shock.

Paulo Roberto Barbosa Evora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24078299      PMCID： PMC3846965          DOI： 10.1007/s13181-013-0333-8

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  4 in total

1.  Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.

Authors:  Daniel Fernandes; José Eduardo da Silva-Santos; Danielle Duma; Christina Gaspar Villela; Christina Barja-Fidalgo; Jamil Assreuy
Journal:  Mol Pharmacol       Date:  2005-12-02       Impact factor: 4.436

2.  Plasma nitrate/nitrite (NOx) is not a useful biomarker to predict inherent cardiopulmonary bypass inflammatory response.

Authors:  Fernanda Viaro; Caroline Floreoto Baldo; Verena Kise Capellini; Andrea Carla Celotto; Solange Bassetto; Alfredo José Rodrigues; Paulo Roberto Barbosa Evora
Journal:  J Card Surg       Date:  2008 Jul-Aug       Impact factor: 1.620

Review 3.  Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.

Authors:  Paulo Roberto Barbosa Evora; Paulo José de Freitas Ribeiro; Walter Vilella de Andrade Vicente; Celso Luís dos Reis; Alfredo José Rodrigues; Antonio Carlos Menardi; Lafaiete Alves Junior; Patrícia Martinez Evora; Solange Bassetto
Journal:  Rev Bras Cir Cardiovasc       Date:  2009 Jul-Sep

Review 4.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09
  4 in total
  5 in total

1.  A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.

Authors:  Rachel Erin Graham; Michaela Cartner; James Winearls
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 2.  Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.

Authors:  Paulo Roberto Barbosa Evora; Lafaiete Alves Junior; Cesar Augusto Ferreira; Antônio Carlos Menardi; Solange Bassetto; Alfredo José Rodrigues; Adilson Scorzoni Filho; Walter Vilella de Andrade Vicente
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar

Review 3.  Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.

Authors:  Filomena Puntillo; Mariateresa Giglio; Alberto Pasqualucci; Nicola Brienza; Antonella Paladini; Giustino Varrassi
Journal:  Adv Ther       Date:  2020-07-23       Impact factor: 3.845

4.  Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis.

Authors:  Cong-Cong Zhao; Yu-Jia Zhai; Zhen-Jie Hu; Yan Huo; Zhi-Qiang Li; Gui-Jun Zhu
Journal:  Front Med (Lausanne)       Date:  2022-09-26

5.  Effect of methylene blue on hemodynamic and metabolic response in septic shock patients.

Authors:  Fabio Luis-Silva; Mayra Gonçalves Menegueti; Corina Dos Reis Sepeda; Bruno C Petroski-Moraes; Lucas Sato; Leandro Moreira Peres; Christiane Becari; Anibal Basile-Filho; Paulo R B Evora; Olindo Assis Martins-Filho; Maria Auxiliadora-Martins
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.